Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis

di McBain, Catherine, Lawrie, Theresa A, Rogozińska, Ewelina, Kernohan, Ashleigh, Robinson, Tomos, Jefferies, Sarah
Pubblicato in Cochrane Database Syst Rev (2021)

Treatment options for recurrent glioblastoma: a network meta‐analysis

di Lawrie, Theresa A, McBain, Catherine, Rogozińska, Ewelina, Kernohan, Ashleigh, Robinson, Tomos, Lawrie, Imogen, Jefferies, Sarah
Pubblicato in Cochrane Database Syst Rev (2020)

QLIF-37. SURVIVORSHIP IN BRAIN METASTASES PATIENTS: THE ROLE OF THE NEURO-ONCOLOGY TEAM IN ADDRESSING EDUCATIONAL NEEDS IN NON-NEURO-ONCOLOGY PROFESSIONALS?

di McBain, Catherine, Robson, Sara, Molloy, Elizabeth, Emerson, Julie, Smith, Charlotte, Leggate, James, Colaco, Rovel, Whitfield, Gillian
Pubblicato in Neuro Oncol (2017)

Improving survivorship in brain metastases patents: assessing and addressing educational needs in non-neuro-oncology health professionals

di Robson, Sara, Molloy, Liz, Smith, Charlotte, Emerson, Julie, Whitfield, Gillian, Colaco, Rovel, Leggate, James, McBain, Catherine
Pubblicato in Neuro Oncol (2018)

CTIM-14. PELAREOREP AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) WITH STANDARD CHEMORADIOTHERAPY/ADJUVANT TEMOZOLOMIDE FOR GLIOBLASTOMA MULTIFORME (GBM) PATIENTS:...

di Kendall, Jessica, Chalmers, Anthony, McBain, Catherine, Melcher, Alan, Samson, Adel, Phillip, Rachel, Brown, Sarah, Short, Susan
Pubblicato in Neuro Oncol (2020)

QLIF-06. DESIGN AND IMPLEMENTATION OF A SURVIVORSHIP PROGRAMME IN AN UNSELECTED COHORT OF NEWLY DIAGNOSED BRAIN TUMOUR PATIENTS: FEASIBILITY AND APPLICATION OF ROUTINE HOLISTIC NEE...

di McBain, Catherine, Emerson, Julie, Molloy, Elizabeth, Robson, Sara, Cundliffe, Sarah, Gilston-Hope, Alison, Smith, Charlotte, Wadeson, Andrea
Pubblicato in Neuro Oncol (2017)

Investigation of the survivorship needs of patients with primary brain tumours and the provision of a health & wellbeing event

di Emerson, Julie, Robson, Sara, Molloy, Liz, Smith, Charlotte, Gilston-hope, Alison, Cundliffe, Sarah, Wadeson, Andrea, McBain, Catherine
Pubblicato in Neuro Oncol (2018)

GE-26 ASSOCIATION BETWEEN FLUORESCENCE IN SITU HYBRIDISATION (FISH) PROBE RATIO SCORES AND SURVIVAL IN 1p/19q CO-DELETED GLIOMAS

di Pinkham, Mark, McBain, Catherine, DuPlessis, Daniel, Telford, Nick, O'Neill, Fran, Gattamaneni, Rao, Tran, Anna, Whitfield, Gillian
Pubblicazione 2014

ACTR-38. A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)

di Saran, Frank, James, Allan, McBain, Catherine, Jefferies, Sarah, Harris, Fiona, Cseh, Agnieszka, Pemberton, Karine, Schaible, Jennifer, Bender, Shaun, Brada, Michael
Pubblicato in Neuro Oncol (2018)

An audit of the management of elderly patients with glioblastoma in the UK: have recent trial results changed treatment?

di Chong, Ming Yao, Lorimer, Cressida F, Mehta, Shaveta, Ibrahim, Ehab, Brock, Juliet, McBain, Catherine, McLoone, Philip, Chalmers, Anthony J
Pubblicato in CNS Oncol (2019)

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis

di Li, Ka-Loh, Djoukhadar, Ibrahim, Zhu, Xiaoping, Zhao, Sha, Lloyd, Simon, McCabe, Martin, McBain, Catherine, Evans, D. Gareth, Jackson, Alan
Pubblicato in Neuro Oncol (2016)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment s...

di Fulton, Ben, Short, Susan C., James, Allan, Nowicki, Stefan, McBain, Catherine, Jefferies, Sarah, Kelly, Caroline, Stobo, Jon, Morris, Anna, Williamson, Aoife, Chalmers, Anthony J.
Pubblicato in Clin Transl Radiat Oncol (2017)

AT-43 MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND PHASE II STUDY COMPARING CEDIRANIB (AZD2171) PLUS GEFITINIB (IRESSA, ZD1839) WITH CEDIRANIB PLUS PLACEBO IN SUBJECTS WITH RECURRENT/PRO...

di Mulholland, Paul, Krell, Daniel, Khan, Iftekhar, McBain, Catherine, Patel, Chaya, Wanek, Katharina, Hopkins, Kirsten, Jeffries, Sarah, Jager, Rolf, Smith, Paul, Liu, Qi, Stupp, Roger, Tomlinson, Ian
Pubblicazione 2014

High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastoma

di Taylor, Jessica, Yu, Kenny, Pathmanaban, Omar, Beyit, Deniz, Dutko-Gwozdz, Joanna, Benson, Rod, Griffiths, Gareth, McBain, Catherine, Peers, Ian, Ceuppens, Peter, Kamaly-asl, Ian, Bigger, Brian
Pubblicato in Neuro Oncol (2018)

NCMP-04. INCIDENCE AND OUTCOMES OF BRAIN METASTASES IN PATIENTS WITH EXTRA-PULMONARY NEUROENDOCRINE NEOPLASMS

di Abedin Kapacee, Zainul, Dawod, Mohammed, Allison, Jennifer, Frizziero, Dr Melissa, Chakrabarty, Bipasha, Manoharan, Prakash, McBain, Catherine, Mansoor, Was, Lamarca, Angela, Hubner, Richard, Valle, Juan, McNamara, Mairead
Pubblicato in Neuro Oncol (2020)

Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma

di Lassen, Ulrik, Chinot, Olivier L., McBain, Catherine, Mau-Sørensen, Morten, Larsen, Vibeke Andrée, Barrie, Maryline, Roth, Patrick, Krieter, Oliver, Wang, Ka, Habben, Kai, Tessier, Jean, Lahr, Angelika, Weller, Michael
Pubblicato in Neuro Oncol (2015)

ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)

di Chalmers, Anthony, Cruickshank, Garth, Dunn, Laurence, Erridge, Sara, Godfrey, Lisa, Herbert, Christopher, Jefferies, Sarah, Lopez, Juanita, McBain, Catherine, Pittman, Marc, Sleigh, Rebecca, Watts, Colin, Webster-Smith, Mark, Halford, Sarah
Pubblicato in Neuro Oncol (2017)

INNV-24. THE EXPERIENCE OF FATIGUED BRAIN TUMOUR PATIENTS RECEIVING INNOVATIVE LIFESTYLE INTERVENTIONS: QUALITATIVE RESULTS FROM THE BT-LIFE RANDOMISED CONTROLLED TRIAL

di Torrens, Claire, Emerson, Julie, Hewins, William, Walker, Amie, Withington, Lisa, Mackinnon, Mairi, Robson, Sara, Dunlop, Jo, Welsh, Michelle, McBain, Catherine, Chalmers, Anthony, Grant, Robin, Rooney, Alasdair G, Wells, Mary
Pubblicato in Neuro Oncol (2020)

EXTH-57. HIGH CONTENT SCREENING OF PATIENT-DERIVED CELL LINES HIGHLIGHTS THE POTENTIAL OF NON-STANDARD CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF RECURRENT GLIOBLASTOMA

di Taylor, Jessica, Yu, Kenny, Pathmanaban, Omar, Beyit, Deniz, Dutko-Gwozdz, Joanna, Benson, Rod, Griffiths, Gareth, Telfer, Brian, Williams, Kaye, Peers, Ian, Ceuppens, Peter, McBain, Catherine, Kamaly-Asl, Ian, Bigger, Brian
Pubblicato in Neuro Oncol (2017)

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma

di Brown, Nicholas, McBain, Catherine, Nash, Stephen, Hopkins, Kirsten, Sanghera, Paul, Saran, Frank, Phillips, Mark, Dungey, Fiona, Clifton-Hadley, Laura, Wanek, Katharina, Krell, Daniel, Jeffries, Sarah, Khan, Iftekhar, Smith, Paul, Mulholland, Paul
Pubblicato in PLoS One (2016)